Zyna Medtech Private Limited - Due diligence report

A 360° intelligence report on Zyna Medtech Private Limited: trust score, financial health, credit view, compliance, directors, growth and di…

2014-02-18 Visakhapatnam, Andhra Pradesh Active Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Zyna Medtech Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
72/100
Trust Score
Moderate

Zyna Medtech Private Limited is assessed as Moderate with a Trust Score of 72/100. Zyna Medtech Private Limited is an active private limited indian non-government company incorporated in 2014, operating in the Energy and Power sector. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 19 Oct 2026 from the latest processed filings. Zyna Medtech Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
72/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MANINDER SINGH LAL 01234567 Director 01/04/2018 6 yrs Approved
REENA SINGH LAL 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Lotus Wireless Technologies India Private Limited
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Lotus Wireless Technologies India Private Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 55
Growth signals & trust indicators
Operating for 12+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence68/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment58/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 8 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
24 Sep 2019
Director ceased
DEBASIS SINHA RAY
Director ceased
BINU SUBRAMANIAM PILLAI
13 Jun 2019
Securities allotted
540000 Equity Shares Without Differential Rights - 54.00 Lakh raised
18 Feb 2014
Incorporated
Registered with Roc Vijayawada
Director appointed
MANINDER SINGH LAL (Director)
Director appointed
REENA SINGH LAL (Director)
10

Key Observations

Auto-generated from the data above
Debt-to-equity stands at 2.1x - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ayuelectronics Private Limited U32509AP2025PTC117566 Visakhapatnam, Andhra Pradesh
Anika Medical Devices Private Limited U33100AP2022PTC122674 Visakhapatnam, Andhra Pradesh
Varivoda Medtech Private Limited U32509AP2024PTC113717 Visakhapatnam, Andhra Pradesh
Griva Healthcare Private Limited U32509AP2025PTC117335 Visakhapatnam, Andhra Pradesh
Deficrafters Private Limited U62013AP2023PTC111799 Visakhapatnam, Andhra Pradesh
ANANTYA VENTURE PARTNERS LLP ABC-7461 Visakhapatnam, Andhra Pradesh
Yagnaksha Medtech India Private Limited U32503AP2023PTC111397 Visakhapatnam, Andhra Pradesh
Brainoption Technology Private Limited U72200AP2019PTC113169 Visakhapatnam, Andhra Pradesh
Univiv Imaging Medtech Private Limited U33132AP2024PTC115110 Visakhapatnam, Andhra Pradesh
Cardiosync Science And Technology Private Limited U32509AP2024PTC115853 Visakhapatnam, Andhra Pradesh
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Zyna Medtech Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Zyna Medtech Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Zyna Medtech Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Zyna Medtech Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Zyna Medtech Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Zyna Medtech Private Limited an active company?

Zyna Medtech Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Zyna Medtech Private Limited financially healthy?

Zyna Medtech Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Zyna Medtech Private Limited?

Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Zyna Medtech Private Limited?

The ultimate holding entity is Lotus Wireless Technologies India Private Limited. 2 active director(s) are on record.

Does Zyna Medtech Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Zyna Medtech Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Zyna Medtech Private Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.